Department of Endocrinology, Obesity and Preventive Medicine, Oslo University Hospital HF, PO Box 4959 Nydalen, 0424 Oslo, Norway.
Eur J Endocrinol. 2012 Oct;167(4):579-88. doi: 10.1530/EJE-12-0452. Epub 2012 Aug 13.
To assess changes in insulin resistance and β-cell function in a multiethnic cohort of women in Oslo, Norway, from early to 28 weeks' gestation and 3 months post partum and relate the findings to gestational diabetes mellitus (GDM).
Population-based cohort study of 695 healthy pregnant women from Western Europe (41%), South Asia (25%), Middle East (15%), East Asia (6%) and elsewhere (13%). Blood samples and demographics were recorded at mean 15 (V1) and 28 (V2) weeks' gestation and 3 months post partum (V3). Universal screening was by 75 g oral glucose tolerance test at V2, GDM with modified IADPSG criteria (no 1-h measurement): fasting plasma glucose (PG) ≥5.1 or 2-h PG ≥8.5 mmol/l. Homeostatic model assessment (HOMA)-β (β-cell function) and HOMA-IR (insulin resistance) were calculated from fasting glucose and C-peptide.
Characteristics were comparable across ethnic groups, except age (South Asians: younger, P<0.001) and prepregnant BMI (East Asians: lower, P=0.040). East and South Asians were more insulin resistant than Western Europeans at V1. From V1 to V2, the increase in insulin resistance was similar across the ethnic groups, but the increase in β-cell function was significantly lower for the East and South Asians compared with Western Europeans. GDM women compared with non-GDM women were more insulin resistant at V1; from V1 to V2, their β-cell function increased significantly less and the percentage increase in β-cell function did not match the change in insulin resistance.
Pregnant women from East Asia and South Asia were more insulin resistant and showed poorer HOMA-β-cell function than Western Europeans.
评估挪威奥斯陆的一个多民族队列中女性的胰岛素抵抗和β细胞功能从早期到妊娠 28 周和产后 3 个月的变化,并将这些发现与妊娠糖尿病(GDM)相关联。
这是一项基于人群的队列研究,共纳入了 695 名来自西欧(41%)、南亚(25%)、中东(15%)、东亚(6%)和其他地区(13%)的健康孕妇。在平均妊娠 15 周(V1)、28 周(V2)和产后 3 个月(V3)时采集血样并记录人口统计学数据。V2 时采用 75g 口服葡萄糖耐量试验进行普遍筛查,采用改良 IADPSG 标准(无 1h 测量值)诊断 GDM:空腹血糖(PG)≥5.1 或 2hPG≥8.5mmol/l。采用空腹血糖和 C 肽计算稳态模型评估(HOMA)-β(β细胞功能)和 HOMA-IR(胰岛素抵抗)。
除年龄(南亚人更年轻,P<0.001)和孕前 BMI(东亚人更低,P=0.040)外,不同种族组的特征具有可比性。与西欧人相比,东亚人和南亚人在 V1 时的胰岛素抵抗更为明显。从 V1 到 V2,不同种族组的胰岛素抵抗增加相似,但东亚人和南亚人的β细胞功能增加明显低于西欧人。与非 GDM 妇女相比,GDM 妇女在 V1 时的胰岛素抵抗更为明显;从 V1 到 V2,她们的β细胞功能增加明显较少,β细胞功能的增加与胰岛素抵抗的变化不匹配。
与西欧人相比,来自东亚和南亚的孕妇胰岛素抵抗更为明显,HOMA-β细胞功能较差。